Cybin (HELP) Enterprise Value (2020 - 2024)
Cybin (HELP) reported Enterprise Value of -$149.6 million for Q4 2024, down 1124.53% on a YoY basis from $14.6 million in Q1 2024, and down 32.25% quarter-over-quarter from -$113.1 million in Q3 2024.
Cybin (HELP) Enterprise Value (2020 - 2024) Analysis & Trends
Cybin has reported Enterprise Value for 5 years, with the latest figure at -$149.6 million in Q4 2024.
- For the quarter ending Q4 2024, Enterprise Value fell 1124.53% year-over-year to -$149.6 million; the trailing twelve-month figure through Dec 2024 stood at -$149.6 million (down 1124.53% YoY), and the FY2024 full-year result was -$155.1 million, changed N/A from the prior year.
- Enterprise Value for Q4 2024 stood at -$149.6 million, down from -$113.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.1 million in Q2 2020, with the low at -$155.1 million in Q1 2024.
- Historically, Enterprise Value has averaged -$51.5 million across 5 years, with a median of -$39.5 million in 2022.
- Annual changes were most pronounced in 2021 — Enterprise Value sank 4574.57% — and 2023, when it surged 69.83%.
- Cybin's Enterprise Value stood at -$3.0 million in 2020, then slumped by 1910.21% to -$59.6 million in 2021, then surged by 33.74% to -$39.5 million in 2022, then jumped by 69.08% to -$12.2 million in 2023, then sank by 1124.53% to -$149.6 million in 2024.
- The last three Enterprise Value figures came in at -$149.6 million (Q4 2024), -$113.1 million (Q3 2024), and -$152.8 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -149.61 Mn |
| Sep 30, 2024 | -113.12 Mn |
| Jun 30, 2024 | -152.80 Mn |
| Mar 31, 2024 | -155.10 Mn |
| Dec 31, 2023 | -12.22 Mn |
| Sep 30, 2023 | -12.41 Mn |
| Jun 30, 2023 | -12.38 Mn |
| Feb 28, 2023 | -32.01 Mn |
| Dec 31, 2022 | -39.52 Mn |
| Sep 30, 2022 | -41.13 Mn |
| May 31, 2022 | -31.99 Mn |
| Feb 28, 2022 | -2.58 Mn |
| Dec 31, 2021 | -59.64 Mn |
| Sep 30, 2021 | -50.86 Mn |
| Jun 30, 2021 | -52.09 Mn |
| Mar 31, 2021 | -50.59 Mn |
| Dec 31, 2020 | -2.97 Mn |
| Sep 30, 2020 | -5.78 Mn |
| Jun 30, 2020 | -1.11 Mn |